ATE410524T1 - Verfahren und nukleinsäuren für die analyse von zellulären proliferationsstörungen - Google Patents

Verfahren und nukleinsäuren für die analyse von zellulären proliferationsstörungen

Info

Publication number
ATE410524T1
ATE410524T1 AT06007989T AT06007989T ATE410524T1 AT E410524 T1 ATE410524 T1 AT E410524T1 AT 06007989 T AT06007989 T AT 06007989T AT 06007989 T AT06007989 T AT 06007989T AT E410524 T1 ATE410524 T1 AT E410524T1
Authority
AT
Austria
Prior art keywords
detecting
nucleic acids
analysis
cellular proliferation
proliferation disorders
Prior art date
Application number
AT06007989T
Other languages
English (en)
Inventor
Catherine Lofton-Day
Andrew Sledziewski
Ralf Lesche
Matthias Schuster
Juergen Distler
Reimo Tetzner
Thomas Hildmann
Fabian Model
Xiaoling Song
Original Assignee
Epigenomics Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36746665&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE410524(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Epigenomics Ag filed Critical Epigenomics Ag
Application granted granted Critical
Publication of ATE410524T1 publication Critical patent/ATE410524T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57525—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the liver or pancreas
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT06007989T 2005-04-15 2006-04-18 Verfahren und nukleinsäuren für die analyse von zellulären proliferationsstörungen ATE410524T1 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US67224205P 2005-04-15 2005-04-15
US67699705P 2005-05-02 2005-05-02
US69752105P 2005-07-08 2005-07-08
US70486005P 2005-08-01 2005-08-01
US70931805P 2005-08-17 2005-08-17
US72360205P 2005-10-04 2005-10-04
US78740206P 2006-03-30 2006-03-30

Publications (1)

Publication Number Publication Date
ATE410524T1 true ATE410524T1 (de) 2008-10-15

Family

ID=36746665

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06007989T ATE410524T1 (de) 2005-04-15 2006-04-18 Verfahren und nukleinsäuren für die analyse von zellulären proliferationsstörungen

Country Status (20)

Country Link
US (8) US7951563B2 (de)
EP (4) EP1877577A2 (de)
JP (2) JP5341506B2 (de)
KR (3) KR20080011287A (de)
CN (3) CN107663538B (de)
AT (1) ATE410524T1 (de)
AU (1) AU2006236620B2 (de)
BR (1) BRPI0607508B8 (de)
CA (1) CA2606296C (de)
DE (1) DE602006003012D1 (de)
DK (1) DK1721992T3 (de)
EA (1) EA013634B1 (de)
ES (2) ES2533767T3 (de)
IL (1) IL186556A (de)
MX (1) MX2007012782A (de)
PL (1) PL1721992T3 (de)
PT (1) PT1721992E (de)
SG (1) SG183708A1 (de)
SI (1) SI1721992T1 (de)
WO (1) WO2006113466A2 (de)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1863927B (zh) 2003-09-04 2010-08-11 人类遗传标记控股有限公司 核酸检测分析
ES2399054T3 (es) 2004-12-03 2013-03-25 Human Genetic Signatures Pty Ltd Métodos para simplificar ácidos nucleicos microbianos mediante modificación química de citosinas
KR20080011287A (ko) * 2005-04-15 2008-02-01 에피제노믹스 아게 세포 증식 질환을 분석하기 위한 방법 및 핵산
AU2006251866B2 (en) * 2005-05-26 2007-11-29 Human Genetic Signatures Pty Ltd Isothermal strand displacement amplification using primers containing a non-regular base
ATE531820T1 (de) 2005-09-14 2011-11-15 Human Genetic Signatures Pty Gesundheitszustandstest
AU2007237444B2 (en) * 2006-04-17 2013-05-23 Epigenomics Ag Methods and nucleic acids for the detection of colorectal cell proliferative disorders
US20080050738A1 (en) * 2006-05-31 2008-02-28 Human Genetic Signatures Pty Ltd. Detection of target nucleic acid
WO2008011620A2 (en) * 2006-07-21 2008-01-24 Epigenomics Ag Methods and nucleic acids for analyses of cellular proliferative disorders
CN101153336B (zh) 2006-09-27 2011-09-07 香港中文大学 检测dna甲基化程度的方法和试剂盒
US7662566B2 (en) * 2006-11-22 2010-02-16 Myriad Genetics, Inc. Gene copy number profiling
CA2676227A1 (en) * 2007-02-12 2008-08-21 The Johns Hopkins University Early detection and prognosis of colon cancers
JP2010521142A (ja) * 2007-03-16 2010-06-24 ヒューマン ジェネティック シグネチャーズ ピーティーワイ リミテッド 遺伝子発現アッセイ
WO2008122447A2 (en) * 2007-04-10 2008-10-16 Epigenomics Ag Dna methylation assay for the diagnosis or prognosis of medical conditions
EP2152902A2 (de) * 2007-06-08 2010-02-17 Epigenomics AG Verfahren zur methylierungsanalyse
FR2919061B1 (fr) * 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage de la plastine-i pour le diagnostic in vitro du cancer colorectal.
AU2008329549B2 (en) 2007-11-27 2013-08-22 Human Genetic Signatures Pty Ltd Enzymes for amplification and copying bisulphite modified nucleic acids
AU2008334901A1 (en) * 2007-12-11 2009-06-18 Epigenomics Ag Methods and nucleic acids for analyses of lung carcinoma
CA2709632A1 (en) * 2007-12-20 2009-07-02 Human Genetic Signatures Pty Ltd Elimination of contaminants associated with nucleic acid amplification
TW200927925A (en) * 2007-12-27 2009-07-01 Agriculture And Food Agency Council Of Agriculture Specific Promoter Region Expresses in Actively Dividing Young Tissues and the Aging Tissues in Plants and its Application
US20110245087A1 (en) * 2008-03-18 2011-10-06 Gunter Weiss Method for optimizing and validating an assay for determining the presence or absence of a medical condition
CA2740046A1 (en) * 2008-10-09 2010-04-15 British Columbia Cancer Agency Branch Detection of granulosa-cell tumors
EP2309005B1 (de) * 2009-08-03 2015-03-04 Epigenomics AG Verfahren zur Konservierung von genomischer DNA-Sequenzkomplexität
TWI434937B (zh) * 2009-10-28 2014-04-21 Univ Nat Chunghsing 具有廣泛性抗木瓜輪點病毒特性的基因轉殖木瓜品系１８－２－４之核酸分子及其檢測方法及應用
GB201004147D0 (en) * 2010-03-12 2010-04-28 Dna Electronics Ltd Method and apparatus for sensing methylation
KR101747191B1 (ko) 2011-01-14 2017-06-14 에스케이하이닉스 주식회사 반도체 장치
GB201107466D0 (en) 2011-05-05 2011-06-15 Loktionov Alexandre Device and method for non-invasive collection of colorectal mucocellular layer and disease detection
US20130065228A1 (en) * 2011-06-01 2013-03-14 University Of Southern California Genome-scale analysis of aberrant dna methylation in colorectal cancer
FI20115709A0 (fi) * 2011-07-01 2011-07-01 Helsingin Yliopisto Menetelmä perinnöllisten syöpien diagnosointiin
CA2840149C (en) * 2011-07-08 2021-10-26 Epigenomics Ag Methods and nucleic acids for determining the prognosis of a cancer subject
DK2753710T3 (en) 2011-09-07 2017-02-06 Human Genetic Signatures Pty Ltd MOLECULAR DETECTION ASSAY
US9546403B1 (en) 2011-12-14 2017-01-17 University Of Utah Research Foundation Substrate for methylated DNA testing
WO2013142545A1 (en) * 2012-03-20 2013-09-26 Exact Sciences Corporation Marker panel for detecting cancer
WO2014032205A1 (zh) * 2012-08-31 2014-03-06 国防医学院 一种癌症筛检的方法
US10706957B2 (en) 2012-09-20 2020-07-07 The Chinese University Of Hong Kong Non-invasive determination of methylome of tumor from plasma
US9732390B2 (en) 2012-09-20 2017-08-15 The Chinese University Of Hong Kong Non-invasive determination of methylome of fetus or tumor from plasma
KR101476769B1 (ko) * 2013-01-02 2014-12-26 대구대학교 산학협력단 leucine-richα-2 glyprotein를 함유하는 대장암 진행예측용 바이오마커 조성물 및 이를 포함하는 대장암 진단용 바이오키트
JP6369857B2 (ja) * 2013-05-29 2018-08-08 シスメックス株式会社 肝細胞癌に関する情報の取得方法、ならびに肝細胞癌に関する情報を取得するためのマーカーおよびキット
KR101527283B1 (ko) * 2013-08-13 2015-06-10 서울대학교산학협력단 당단백질의 탈당화 검출을 통한 암 마커 스크리닝 방법 및 간세포암 마커
KR101438519B1 (ko) * 2014-07-01 2014-09-17 대구대학교 산학협력단 complement factor B를 함유하는 대장암 진행예측용 바이오마커 조성물 및 이를 포함하는 대장암 진단용 바이오키트
EP3164039B1 (de) 2014-07-03 2018-06-13 Aktiebolaget Electrolux Mischanordnung für haushaltsgeräte
WO2016000781A1 (en) 2014-07-03 2016-01-07 Aktiebolaget Electrolux Household appliance mixing arrangement
US11062789B2 (en) 2014-07-18 2021-07-13 The Chinese University Of Hong Kong Methylation pattern analysis of tissues in a DNA mixture
CN104745575B (zh) * 2014-08-08 2019-03-12 博诚研究中心 用于检测细胞增殖性异常或疾病程度分级的基因组合物及其用途
HRP20190787T1 (hr) * 2014-12-19 2019-08-09 Epigenomics Ag Metoda otkrivanja cpg (na mjestima citozin-fosfat-guanin)metilacije i dijagnosticiranje karcinoma
WO2016101258A1 (zh) * 2014-12-26 2016-06-30 北京大学 一种检测与人体异常状态相关的差异甲基化CpG岛的方法
CN106148501A (zh) * 2015-04-23 2016-11-23 博诚研究中心 一种检测Septin9基因甲基化的试剂盒及其应用
CN104830855A (zh) * 2015-05-21 2015-08-12 基因科技（上海）有限公司 一种检测sept9基因甲基化的探针及其应用
EP3452620B1 (de) * 2016-05-04 2025-11-05 Queen's University at Kingston Zellfreier nachweis von methylierter tumor-dna
RU2630669C1 (ru) * 2016-07-21 2017-09-11 Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" (ФБУН ГНЦ ВБ "Вектор") Способ определения метилирования сайтов PuCGPy регуляторных областей генов-онкомаркеров колоректального рака методом GLAD-ПЦР-анализа и набор олигонуклеотидных праймеров и флуоресцентно-меченых зондов для осуществления указанного способа
WO2018031760A1 (en) 2016-08-10 2018-02-15 Grail, Inc. Methods of preparing dual-indexed dna libraries for bisulfite conversion sequencing
CN107723363A (zh) * 2016-08-11 2018-02-23 博尔诚（北京）科技有限公司 肿瘤标志物的组合检测方法及其应用
KR102921023B1 (ko) 2016-11-30 2026-01-30 더 차이니즈 유니버시티 오브 홍콩 소변 및 기타 샘플에서의 무세포 dna의 분석
EP3360971A1 (de) * 2017-02-09 2018-08-15 Epiontis GmbH Verbessertes verfahren zur epigenetischen immunzellenzählung
JP7220200B2 (ja) 2017-04-19 2023-02-09 シングレラ ジェノミクス， インコーポレイテッド ライブラリー構築および配列解析のための組成物および方法
CN109609629A (zh) * 2017-09-30 2019-04-12 博尔诚（北京）科技有限公司 用于检测肝癌的组合物及其用途
WO2019178277A1 (en) 2018-03-13 2019-09-19 Grail, Inc. Anomalous fragment detection and classification
GB2587939B (en) 2018-04-02 2023-06-14 Grail Llc Methylation markers and targeted methylation probe panels
CN108866192B (zh) * 2018-07-26 2021-06-22 上海奕谱生物科技有限公司 基于甲基化修饰的肿瘤标记物stamp-ep1
CN108866191B (zh) * 2018-07-26 2021-07-09 上海奕谱生物科技有限公司 基于甲基化修饰的肿瘤标记物stamp-ep2
CA3111887A1 (en) 2018-09-27 2020-04-02 Grail, Inc. Methylation markers and targeted methylation probe panel
WO2020132572A1 (en) 2018-12-21 2020-06-25 Grail, Inc. Source of origin deconvolution based on methylation fragments in cell-free-dna samples
CN116064815B (zh) * 2019-02-14 2024-12-03 博尔诚（北京）科技有限公司 一种食管癌、胃癌、肠癌、肝癌和/或胰腺癌患癌、癌前筛查组合物及其用途
CN110211633B (zh) * 2019-05-06 2021-08-31 臻和精准医学检验实验室无锡有限公司 Mgmt基因启动子甲基化的检测方法、测序数据的处理方法及处理装置
CN112063712A (zh) * 2019-10-28 2020-12-11 北京康美天鸿生物科技有限公司 基于高分辨率熔解曲线检测septin9基因甲基化的特异引物对和试剂盒
WO2021122799A1 (en) * 2019-12-16 2021-06-24 Epigenomics Ag Methods for detecting colorectal cancer
KR102637032B1 (ko) * 2020-01-28 2024-02-15 주식회사 젠큐릭스 특정 유전자의 CpG 메틸화 변화를 이용한 방광암 진단용 조성물 및 이의 용도
WO2023017001A1 (en) 2021-08-09 2023-02-16 Epigenomics Ag Improved methods for detecting colorectal cancer
CN113584032B (zh) * 2021-08-20 2023-08-29 深圳市恩辑生物科技有限公司 一种迷你启动子pAPP及其应用
CN113862349A (zh) * 2021-10-26 2021-12-31 山东师范大学 一种肺纤维化诊断生物标志物
CN114783511B (zh) * 2022-02-25 2025-03-25 深圳市硬核酸生物科技有限公司 核酸分子溶液浓度推荐方法及装置、计算机设备
WO2024074558A1 (en) 2022-10-04 2024-04-11 Epigenomics Ag Improved methods for detecting cancer
WO2025019568A1 (en) * 2023-07-17 2025-01-23 The Penn State Research Foundation Improving immune cell-based therapies against solid tumors with optogenetically engineered septin proteins

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585481A (en) 1987-09-21 1996-12-17 Gen-Probe Incorporated Linking reagents for nucleotide probes
US5457183A (en) 1989-03-06 1995-10-10 Board Of Regents, The University Of Texas System Hydroxylated texaphyrins
US5245022A (en) 1990-08-03 1993-09-14 Sterling Drug, Inc. Exonuclease resistant terminally substituted oligonucleotides
US5565552A (en) * 1992-01-21 1996-10-15 Pharmacyclics, Inc. Method of expanded porphyrin-oligonucleotide conjugate synthesis
US5574142A (en) * 1992-12-15 1996-11-12 Microprobe Corporation Peptide linkers for improved oligonucleotide delivery
SE501439C2 (sv) 1993-06-22 1995-02-13 Pharmacia Lkb Biotech Sätt och anordning för analys av polynukleotidsekvenser
KR100392057B1 (ko) 1993-11-30 2003-10-30 맥길 유니버시티 세포의 CpG 디뉴클레오티드 내의 시토신의 메틸화를 감소하는 방법
US5597696A (en) 1994-07-18 1997-01-28 Becton Dickinson And Company Covalent cyanine dye oligonucleotide conjugates
US5514758A (en) 1994-09-30 1996-05-07 The Goodyear Tire & Rubber Company Process for making latex for high performance masking tape
US5871917A (en) 1996-05-31 1999-02-16 North Shore University Hospital Research Corp. Identification of differentially methylated and mutated nucleic acids
US6017704A (en) 1996-06-03 2000-01-25 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
US5786146A (en) 1996-06-03 1998-07-28 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
JPH1090169A (ja) 1996-09-19 1998-04-10 Bunshi Bio Photonics Kenkyusho:Kk 顕微鏡装置
KR20000048838A (ko) 1996-10-01 2000-07-25 랍폴트-회르프란트 구트룬 사람의 성장 유전자 및 작은 키 유전자 영역
US6251594B1 (en) * 1997-06-09 2001-06-26 Usc/Norris Comprehensive Cancer Ctr. Cancer diagnostic method based upon DNA methylation differences
DE19754482A1 (de) 1997-11-27 1999-07-01 Epigenomics Gmbh Verfahren zur Herstellung komplexer DNA-Methylierungs-Fingerabdrücke
GB9726539D0 (en) 1997-12-16 1998-02-11 Univ Dundee Polypeptides, polynucleotides and uses thereof
GB9805918D0 (en) * 1998-03-19 1998-05-13 Nycomed Amersham Plc Sequencing by hybridisation
AUPP312998A0 (en) * 1998-04-23 1998-05-14 Commonwealth Scientific And Industrial Research Organisation Diagnostic assay
US7700324B1 (en) 1998-11-03 2010-04-20 The Johns Hopkins University School Of Medicine Methylated CpG island amplification (MCA)
US5958773A (en) 1998-12-17 1999-09-28 Isis Pharmaceuticals Inc. Antisense modulation of AKT-1 expression
JP2000221136A (ja) 1999-01-29 2000-08-11 Jasco Corp 経時変化追跡方法および装置
US6331393B1 (en) 1999-05-14 2001-12-18 University Of Southern California Process for high-throughput DNA methylation analysis
US6783933B1 (en) * 1999-09-15 2004-08-31 The Johns Hopkins University School Of Medicine CACNA1G polynucleotide, polypeptide and methods of use therefor
WO2001029254A2 (en) * 1999-10-19 2001-04-26 Universiteit Gent Identification of bpesc1, a gene disrupted by a balanced chromosomal translocation t(3;4) (q23;p15.2) in a patient with bpes
JP3783826B2 (ja) 2000-01-17 2006-06-07 横河電機株式会社 バイオチップ読み取り装置
WO2005000087A2 (en) * 2003-06-03 2005-01-06 Chiron Corporation Gene products differentially expressed in cancerous colon cells and their methods of use ii
IL154663A0 (en) * 2000-09-01 2003-09-17 Epigenomics Ag Method for determining the degree of methylation of defined cytosines in genomic dna in the sequence context 5'-cpg-3'
US6756200B2 (en) * 2001-01-26 2004-06-29 The Johns Hopkins University School Of Medicine Aberrantly methylated genes as markers of breast malignancy
DE10112515B4 (de) * 2001-03-09 2004-02-12 Epigenomics Ag Verfahren zum Nachweis von Cytosin-Methylierungsmustern mit hoher Sensitivität
US7473767B2 (en) 2001-07-03 2009-01-06 The Institute For Systems Biology Methods for detection and quantification of analytes in complex mixtures
WO2003064682A1 (en) * 2001-10-18 2003-08-07 Lovelace Respiratory Research Institute Cancer monitoring by aberrant promotor methylation of the transcription factor genes pax5 alpha pax5 beta, novel loop helix loop protein, novel gene 2, and beta3 genes
WO2003042661A2 (en) 2001-11-13 2003-05-22 Protein Design Labs, Inc. Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
JP3448654B2 (ja) 2001-11-22 2003-09-22 北陸先端科学技術大学院大学長 バイオチップ、バイオチップアレイ、及びそれらを用いたスクリーニング方法
AU2002353043B2 (en) 2001-11-30 2008-07-03 The Johns Hopkins University Methods for analyzing methylated CpG islands and GC rich regions
JP2003232725A (ja) 2002-02-12 2003-08-22 Japan Science & Technology Corp 表面プラズモン共鳴測定法を用いる化学反応解析センサ
DE10228917A1 (de) 2002-06-24 2004-01-22 Epigenomics Ag Vorrichtung zur Handhabung von Flüssigkeiten in einer Mehrzahl von Kanälen
JP4199609B2 (ja) 2002-07-12 2008-12-17 三菱化学株式会社 分析用チップ、分析用チップユニット及び分析装置ならびに分析用チップの作製方法
ATE400552T1 (de) 2002-07-16 2008-07-15 Inst Nat Sante Rech Med 4,4' -dithiobis- (3-aminobutane-1-sulfonate)- derivate und sie enthaltende zusammensetzungen
DE10317955A1 (de) 2003-04-17 2004-11-25 Epigenomics Ag Verfahren und Nukleinsäuren für die verbesserte Behandlung von proliferativen Erkrankungen von Brustzellen
US20060024684A1 (en) 2002-10-01 2006-02-02 Epigenomics Ag Prognostic markers for prediction of treatment response and/or survival of breast cell proliferative disorder patients
DE10245779A1 (de) 2002-10-01 2004-04-29 Epigenomics Ag Verfahren und Nukleinsäuren für die verbesserte Behandlung von proliferativen Erkrankungen von Brustzellen
DE60328618D1 (de) 2002-10-01 2009-09-10 Epigenomics Ag Verfahren für die behandlung von proliferativen erkrankungen von brustzellen
JP2004156911A (ja) 2002-11-01 2004-06-03 Osaka Industrial Promotion Organization 表面プラズモン蛍光顕微鏡、および表面プラズモンにより励起された蛍光を測定する方法
JP2004212204A (ja) 2002-12-27 2004-07-29 Olympus Corp 蛍光顕微鏡及び蛍光寿命の測定方法、並びに蛍光寿命の測定用プログラム
WO2004074441A2 (en) * 2003-02-19 2004-09-02 Government Of The United States Of America Represented By The Secretary Department Of Health And Human Services Amplification or overexpression of mll septin-like fusion (msf) and septin9 and methods related thereto
EP2354248B1 (de) 2003-06-23 2018-01-03 Epigenomics AG Verfahren zur Analyse von Störungen der Proliferation kolorektaler Zellen
US20040265833A1 (en) * 2003-06-23 2004-12-30 Cathy Lofton-Day Methods and nucleic acids for the analysis of colorectal cell proliferative disorders
EP2088210A3 (de) 2003-10-09 2009-11-18 Epigenomics AG Verbesserte Bisulfit-Umwandlung von DNA
DE10348407A1 (de) 2003-10-17 2005-05-19 Widschwendter, Martin, Prof. Prognostische und diagnostische Marker für Zell-proliferative Erkrankungen von Brustgeweben
CA2544708A1 (en) 2003-11-03 2005-05-12 Genenews, Inc. Liver cancer biomarkers
JP4824575B2 (ja) 2003-12-01 2011-11-30 エピゲノミクス アクチェンゲゼルシャフト 前立腺細胞増殖性疾患の発症に関連する遺伝子発現の分析のための方法および核酸
DE602004031405D1 (de) 2003-12-11 2011-03-31 Epigenomics Ag Marker zur Prognose der Reaktion auf Therapie bzw. der Überlebensrate von Brustkrebspatienten
EP1561821B1 (de) 2003-12-11 2011-02-16 Epigenomics AG Marker zur Prognose der Reaktion auf Therapie bzw. der Überlebensrate von Brustkrebspatienten
EP1756311A2 (de) 2004-05-17 2007-02-28 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Berlin Silencing von tumorsuppressorgenen durch cpg-methylierung bei prostatakrebs
DE102004029700A1 (de) 2004-06-15 2006-02-09 Epigenomics Ag Verfahren zur Quantifizierung methylierter DNA
WO2005123945A2 (en) 2004-06-21 2005-12-29 Epigenomics Ag Epigenetic markers for the treatment of breast cancer
EP2281902A1 (de) * 2004-07-18 2011-02-09 Epigenomics AG Epigenetische Verfahren und Nukleinsäuren für den Nachweis von proliferativen Erkrankungen von Mammazellen
JP4192862B2 (ja) 2004-07-20 2008-12-10 ダイソー株式会社 ポリエーテル系共重合体の製造方法
CA2589782A1 (en) 2004-11-30 2006-06-08 Veridex Llc Lung cancer prognostics
JP5745202B2 (ja) * 2004-12-02 2015-07-08 エピゲノミックス アクチェンゲゼルシャフト 前立腺細胞増殖障害の予後に関連する遺伝子発現分析のための方法および核酸
KR20080011287A (ko) * 2005-04-15 2008-02-01 에피제노믹스 아게 세포 증식 질환을 분석하기 위한 방법 및 핵산
EP1904649A2 (de) 2005-07-18 2008-04-02 Epigenomics AG Zusammenstellung und verfahren zur krebsdiagnostik mit hilfe von pan-krebs-marker
WO2007115213A2 (en) 2006-03-30 2007-10-11 Epigenomics Ag Methods and nucleic acids for analyses of cellular proliferative disorders
AU2007237444B2 (en) 2006-04-17 2013-05-23 Epigenomics Ag Methods and nucleic acids for the detection of colorectal cell proliferative disorders

Also Published As

Publication number Publication date
WO2006113466A8 (en) 2012-04-12
WO2006113466A3 (en) 2007-01-18
US20220154287A1 (en) 2022-05-19
WO2006113466A2 (en) 2006-10-26
IL186556A0 (en) 2008-01-20
BRPI0607508B1 (pt) 2021-01-12
IL186556A (en) 2014-05-28
US20060286576A1 (en) 2006-12-21
KR20130021400A (ko) 2013-03-05
KR20150006089A (ko) 2015-01-15
US8900829B2 (en) 2014-12-02
EP1721992A2 (de) 2006-11-15
US20110039719A1 (en) 2011-02-17
AU2006236620A1 (en) 2006-10-26
EP2045335A1 (de) 2009-04-08
EP1877577A2 (de) 2008-01-16
EA013634B1 (ru) 2010-06-30
US20160304964A1 (en) 2016-10-20
US7951563B2 (en) 2011-05-31
DE602006003012D1 (de) 2008-11-20
CN104046686B (zh) 2017-07-28
PL1721992T3 (pl) 2009-04-30
EP1721992B1 (de) 2008-10-08
KR20080011287A (ko) 2008-02-01
US20110244458A1 (en) 2011-10-06
US9695478B2 (en) 2017-07-04
PT1721992E (pt) 2009-01-14
BRPI0607508A2 (pt) 2009-09-15
ES2533767T3 (es) 2015-04-15
MX2007012782A (es) 2008-03-14
DK1721992T3 (da) 2009-02-02
CA2606296C (en) 2019-05-21
JP2008538497A (ja) 2008-10-30
EP1721992A3 (de) 2006-12-20
CN107663538A (zh) 2018-02-06
SG183708A1 (en) 2012-09-27
CA2606296A1 (en) 2006-10-26
BRPI0607508B8 (pt) 2021-07-27
SI1721992T1 (sl) 2009-04-30
EA200702203A1 (ru) 2008-04-28
US20190316210A1 (en) 2019-10-17
JP5808306B2 (ja) 2015-11-10
US7749702B2 (en) 2010-07-06
EP2045335B1 (de) 2014-12-31
CN104046686A (zh) 2014-09-17
HK1202137A1 (en) 2015-09-18
HK1250521A1 (zh) 2018-12-21
ES2315956T3 (es) 2009-04-01
EP2009115A2 (de) 2008-12-31
AU2006236620B2 (en) 2012-02-23
CN114921544A (zh) 2022-08-19
JP2013090629A (ja) 2013-05-16
EP2009115A3 (de) 2009-02-25
CN107663538B (zh) 2022-03-18
US20150086989A1 (en) 2015-03-26
JP5341506B2 (ja) 2013-11-13
KR101708544B1 (ko) 2017-02-20
US10385402B2 (en) 2019-08-20
US11186879B2 (en) 2021-11-30
US20090075260A1 (en) 2009-03-19

Similar Documents

Publication Publication Date Title
ATE410524T1 (de) Verfahren und nukleinsäuren für die analyse von zellulären proliferationsstörungen
ATE549418T1 (de) Verfahren und nukleinsäuren zur analyse proliferativer zellerkrankungen
WO2007118704A3 (en) Methods and nucleic acids for the detection of colorectal cell proliferative disorders
DE602007011301D1 (de) Verfahren zum nachweis mutanter allele mit kombination von echtzeit-pcr und rems-pcr
WO2005001141A3 (en) Methods and nucleic acids for analyses of colorectal cell proliferative disorders
ATE376596T1 (de) Verfahren und nukleinsäuren zur analyse von störungen der proliferation kolorektaler zellen
WO2009074328A3 (en) Methods and nucleic acids for analyses of lung carcinoma
DE60326748D1 (de) Verfahren zur identifizierung des brustkrebsrisikos
EP1794318A4 (de) Arzneistoff-screening und molekularer diagnosetest zum frühen nachweis von kolorektalkarzinom: reagentien, verfahren und kits dafür
WO2008011620A3 (en) Methods and nucleic acids for analyses of cellular proliferative disorders
WO2008008983A3 (en) Methods and nucleic acids for analyses of cellular proliferative disorders
ATE494390T1 (de) Verfahren und nukleinsäuren zur analyse von störungen der proliferation von kolonzellen
WO2006034879A3 (en) Epigenetic methods and nucleic acids for the detection of lung cell proliferative disorders
EP2660337A3 (de) Verfahren und Nukleinsäuren für Analysen von Zellproliferationsstörungen
WO2009065511A3 (en) Methods and nucleic acids for the analysis of gene expression associated with the development of prostate cell proliferative disorders
WO2007115213A3 (en) Methods and nucleic acids for analyses of cellular proliferative disorders
WO2010070637A3 (en) Method for distinguishing between adrenal tumors
DE602005022658D1 (de) Verfahren und Gerät zur Analyse von Nukleinsäure-Amplifikation
DE502004007990D1 (de) Analyse und verwendung von par 1 polymorphismen zur risikoabschätzung für kardiovaskuläre erkrankungen
ATE490342T1 (de) Zusammensetzungen und verfahren zum nachweis von streptokokken der gruppe b

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1721992

Country of ref document: EP